Related Experiment Video

Updated: May 16, 2025

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
06:46

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis

Published on: February 25, 2022

1.8K

Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugs

Florian Rieder1,2,3, Laura E Nagy4,5, Toby M Maher6,7

  • 1Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. riederf@ccf.org.

Nature Reviews. Drug Discovery
|March 31, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

51.9K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.2K

Related Experiment Videos

Last Updated: May 16, 2025

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
06:46

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis

Published on: February 25, 2022

1.8K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

51.9K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.2K

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

3.0K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.0K

Articles linked to this work by shared authors, journal, and citation graph.

Preferential phosphodiesterase inhibition as a novel strategy to modulate key pathways in systemic sclerosis.

Frontiers in immunology·2026

Predicting prevalence and severity of cytokine release syndrome after CAR T-cell therapy in patients with autoimmune disease: a retrospective cohort study.

The Lancet. Rheumatology·2026

[Oxalate-rare crystal disease in joints and kidneys].

Zeitschrift fur Rheumatologie·2026

Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design.

Annals of the rheumatic diseases·2026

The synergistic impact of granulocytic myeloid-derived suppressor cells and innate lymphoid cells in systemic sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

A first-in-human study of CAL101, a monoclonal antibody targeting S100A4.

British journal of clinical pharmacology·2026

Translating base editors: a decade of progress from the bench to the clinic.

Nature reviews. Drug discovery·2026

Next-generation immune cell engagers for B cell depletion in autoimmune diseases.

Nature reviews. Drug discovery·2026

Soft drugs: design principles and topical applications.

Nature reviews. Drug discovery·2026

The cellular landscape of druggable RNA-binding proteins.

Nature reviews. Drug discovery·2026

Refining therapeutic targeting of interleukin-6 by signalling mode selectivity.

Nature reviews. Drug discovery·2026

The evolving landscape of drug targets.

Nature reviews. Drug discovery·2026

Regulatory-Driven Pharmacokinetic and Immunogenicity Study of Siltartoxatug, a Recombinant Native Human Monoclonal Antibody Against Tetanus Toxin, in Cynomolgus Monkeys.

Advances in pharmacological and pharmaceutical sciences·2026

The impact of an adaptive patient-centered web application on medication optimization in patients with HFrEF: Rationale and design of the SmartHF trial.

American heart journal plus : cardiology research and practice·2026

Non-eligibility for highly effective modulator therapy with elexacaftor/tezacaftor/ivacaftor in cystic fibrosis: What about Portugal?

Pulmonology·2026

Real-World Patient Eligibility for Alzheimer's Disease Anti-Amyloid Therapy in Seven Swedish Memory Clinics.

European journal of neurology·2026

Novel Technologies and Clinical Breakthroughs: The Evolving Landscape of Gene Therapy in China.

Human gene therapy·2026

Advances in the Role of Chemokines in Microwave Ablation-Based Combinatorial Immunotherapy.

Cancer science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us